Expert Review of Clinical Immunology

投稿咨询

官方网站：http://www.tandfonline.com/toc/ierm20/current#.V48dSUz9cSQ

投稿网址：https://mc.manuscriptcentral.com/erm

PMC链接：http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1744-666X%5BISSN%5D

《临床免疫学专家评论》(ISSN 1744-666X)就临床免疫学中新的治疗和诊断模式的表现提供专家分析和评论。临床免疫学专家评审国际编辑咨询小组的成员是他们专业领域的前沿。本小组与我们专业的编辑团队合作，确定最重要和最热门的评论主题，以及最适合提供评论和分析的相应专家。所有的文章都经过严格的同行评审，完成的评审为临床免疫学的决策提供了重要的帮助。文章的重点放在以下几个关键领域:?对特异性免疫疾病的治疗综述，强调最佳治疗方法和新药的前景?新批准的治疗药物的性能和益处?新的诊断方法?筛查和患者分层?Pharmacoeconomic研究?现有疗法的新治疗适应症?不良反应、发生和减少?药物在接近监管批准的后期试验中的前景?新颖的治疗策略?流行病学研究?治疗指南的评论和比较

Expert Review of Clinical Immunology (ISSN 1744-666X) provides expert analysis and commentary regarding the performance of new therapeutic and diagnostic modalities in clinical immunology. Members of the International Editorial Advisory Panel of Expert Review of Clinical Immunology are the forefront of their area of expertise. This panel works with our dedicated editorial team to identify the most important and topical review themes and the corresponding expert(s) most appropriate to provide commentary and analysis. All articles are subject to rigorous peer-review, and the finished reviews provide an essential contribution to decision-making in clinical immunology. Articles focus on the following key areas:? Therapeutic overviews of specific immunologic disorders highlighting optimal therapy and prospects for new medicines ? Performance and benefits of newly approved therapeutic agents ? New diagnostic approaches ? Screening and patient stratification ? Pharmacoeconomic studies ? New therapeutic indications for existing therapies ? Adverse effects, occurrence and reduction ? Prospects for medicines in late-stage trials approaching regulatory approval ? Novel treatment strategies ? Epidemiological studies ? Commentary and comparison of treatment guidelines